Accessibility Menu
Psyence Biomedical logo

Psyence Biomedical

(NASDAQ) PBM

Current Price$2.91
Market Cap$811.70K
Since IPO (2021)-100%
5 YearN/A
1 Year-91%
1 Month-31%

Psyence Biomedical Financials at a Glance

Market Cap

$811.70K

Revenue (TTM)

$0.00

Net Income (TTM)

-$26.25M

EPS (TTM)

$0.00

P/E Ratio

-0.03

Dividend

$0.00

Beta (Volatility)

1.91 (High)

Price

$2.91

Volume

347

Open

$2.91

Previous Close

$2.91

Daily Range

$2.91 - $2.91

52-Week Range

$1.92 - $74.94

Estimated Earnings Date

Jun 24, 2026

PBM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Psyence Biomedical

Industry

Biotechnology

Employees

12

CEO

Marc Balkin

Headquarters

Toronto, ON M5H2K1, CA

PBM Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-58.62%

Return on Capital

-36.81%

Return on Assets

-39.48%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$811.70K

Shares Outstanding

299.50K

Volume

347

Avg. Volume

2.58M

Financials (TTM)

Gross Profit

-$2.35K

Operating Income

-$3.47M

EBITDA

-$2.11M

Operating Cash Flow

-CA$1.05M

Capital Expenditure

-CA$7.80

Free Cash Flow

-CA$1.05M

Cash & ST Invst.

$7.20M

Total Debt

$0.00

Psyence Biomedical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$1.33K

N/A

Gross Margin

0.00%

N/A

Market Cap

$811.70K

N/A

Market Cap/Employee

$67.64K

N/A

Employees

12

N/A

Net Income

-$753.25K

-1098.6%

EBITDA

-$749.17K

-799.9%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

$7.20M

+73325.6%

Total Debt

$0.00

-100.0%

Accounts Receivable

$174.19K

+159.3%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-39.48%

N/A

Return on Invested Capital

-36.81%

N/A

Free Cash Flow

-$665.00

+99.2%

Operating Cash Flow

-$662.00

+99.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DRMADermata Therapeutics, Inc.
$1.29+9.32%
PTIXProtagenic Therapeutics, Inc.
$0.36+0.00%
LIPOLipella Pharmaceuticals Inc.
$0.09+8.43%
SPRCSciSparc Ltd.
$5.70-6.71%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$7.83+0.02%
HLHecla Mining
$15.54+0.03%
INTCIntel
$128.32-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.67+0.04%

Questions About PBM

What is the current price of Psyence Biomedical?

Psyence Biomedical is trading at $2.91 per share.

What is the 52-week range for Psyence Biomedical?

Over the past 52 weeks, Psyence Biomedical has traded between $1.92 and $74.94.

How much debt does Psyence Biomedical have?

As of the most recent reporting period, Psyence Biomedical reported total debt of $0.00.

How much cash does Psyence Biomedical have on hand?

Psyence Biomedical reported $7.20M in cash and cash equivalents in its most recent financial results.

What is Psyence Biomedical’s dividend yield?

Psyence Biomedical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.